FDAFDA · Food and drugs·Recall number D-0656-2020
Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX
Published January 22, 2020 · Recall initiated: December 17, 2019
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- Motto International Corp
- Distributor
- TX
- Lot
- All lots remaining within expiry.
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.